Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate Quest Diagnostics Inc before investing.

In this article, we go over a few key elements for understanding Quest Diagnostics Inc’s stock price such as:

• Quest Diagnostics Inc’s current stock price and volume
• Why Quest Diagnostics Inc’s stock price changed recently
• Upgrades and downgrades for DGX from analysts
• DGX’s stock price momentum as measured by its relative strength

About Quest Diagnostics Inc (DGX)

Before we jump into Quest Diagnostics Inc’s stock price, history, target price and what caused it to recently dip, let’s take a look at some background.

Quest Diagnostics Incorporated is a provider of diagnostic information services. The Company provides diagnostic insights from the results of its laboratory testing to enable people, physicians, and organizations to take action to improve health outcomes. It operates through the DIS segment, which provides diagnostic information services to a range of customers within its primary customer channels: physicians, hospitals, and patients and consumers. It offers broad access to clinical testing through a nationwide network of laboratories, patient service centers, phlebotomists in physician offices, and connectivity resources, including call centers and mobile phlebotomists, nurses and other health and wellness professionals. The Company also focuses on artificial intelligence (AI) and digital pathology solutions for biopharmaceutical companies and pathology laboratories. It has implemented AI, digital and automation technologies across several laboratory and business functions.

Want to learn more about Quest Diagnostics Inc’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about Quest Diagnostics Inc.

Quest Diagnostics Inc’s Stock Price as of Market Close

As of July 23, 2024, 4:00 PM, CST, Quest Diagnostics Inc’s stock price was $140.96.

Quest Diagnostics Inc is down 4.34% from its previous closing price of $147.35.

During the last market session, Quest Diagnostics Inc’s stock traded between $145.72 and $148.26. Currently, there are 111.00 million shares of Quest Diagnostics Inc stock available for purchase.

Quest Diagnostics Inc’s price-earnings (P/E) ratio is currently at 19.8, which is low compared to the Healthcare Facilities & Services industry median of 22.6. The price-earnings ratio gauges market expectation of future performance by relating a stock’s current share price to its earnings per share.

Quest Diagnostics Inc Stock Price History

Quest Diagnostics Inc’s (DGX) price is currently up 2.98% so far this month.

During the month of July, Quest Diagnostics Inc’s stock price has reached a high of $150.59 and a low of $136.30.

Over the last year, Quest Diagnostics Inc has hit prices as high as $150.59 and as low as $119.59. Year to date, Quest Diagnostics Inc’s stock is down 9.9%.

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

What Caused Quest Diagnostics Inc Stock’s Price to Dip?

Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?

When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. As of July 22, 2024, there were 0 analysts who downgraded Quest Diagnostics Inc’s stock and 2 analysts who upgraded over the last month.

Additionally, you'll want to evaluate Quest Diagnostics Inc’s financial health and valuation. Investors can use AAII's Value Grade, which combines six key valuation metrics like P/E and P/S ratios for a comprehensive analysis to conduct analysis on Quest Diagnostics Inc’s valuation and financial health. This approach mitigates the limitations of single-metric evaluations.

Quest Diagnostics Inc’s current valuation based on AAII’s Value Grade is a C, which means it is considered to be Average.

Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.

Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about Quest Diagnostics Inc (DGX) by visiting AAII Stock Evaluator.

Relative Price Strength of Quest Diagnostics Inc

Relative price strength measures a stock's performance against the market, helping investors identify stocks that are outperforming benchmarks.

For AAII’s Momentum Grade, a weighted relative price strength is calculated. Follow this link to learn more about the Momentum Grade.

As of July 22, 2024, Quest Diagnostics Inc has a weighted four-quarter relative price strength of -3.13%, which translates to a Momentum Score of 55 and is considered to be Average.

Want to learn more about how Quest Diagnostics Inc is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.

Quest Diagnostics Inc Stock Price: Bottom Line

As of July 23, 2024, Quest Diagnostics Inc’s stock price is $140.96, which is down 4.34% from its previous closing price.

AAII advises against making stock decisions based solely on price or past returns. Instead, consider a variety of metrics, fundamentals, and analytics to evaluate a stock like Quest Diagnostics Inc stock prices are influenced by market supply and demand and offer just a snapshot of a company's overall health.

Subscribing to AAII's A+ Investor provides access to comprehensive analytics and insights for confident investing.